NOTE: ZIP files requires WinZip which is available at: http://www.winzip.com.
NEW! Customer Concerns and Suggestions Survey
Prescribing Opioid for Chronic Pain (pdf - 11kb)
Prescribing Opioid for Chronic Pain Brochure (pdf - 119kb)
Levothyroxine Sodium REMOVED from the
Florida Negative Drug Formulary
On January 28, 2008, the Division of Administrative Hearings entered a summary final order in favor of Mylan Pharmaceuticals, Inc., in case number 07-3704RX, Mylan Pharmaceuticals, Inc. vs. Department of Health, Board of Medicine and Board of Pharmacy and Abbott Laboratories to remove Levothyroxine Sodium from the Florida Negative Drug Formulary. As a result of this summary final order, the Board of Pharmacy voted, at its April 8-9, 2008 board meeting, to remove Levothyroxine Sodium from the Florida Negative Drug Formulary.
Pursuant to section 465.025(6)(b), Florida Statutes (F.S.), the Board of Pharmacy sent the attached notice to the manager of the prescription department for each permitted community pharmacy located in this state and each registered nonresident pharmacy. This email will serve as notification to each board that regulates practitioners licensed by the laws of the state to prescribe drugs that Levothyroxine Sodium has been removed from the Florida Negative Drug Formulary. Pursuant to section 465.025(6)(b), F.S., each board that regulates practitioners licensed by the laws of the state to prescribe drugs must incorporate the Florida Negative Drug Formulary into its rules.
(Note: Under Florida law, e-mail addresses are public records. If you do not want your e-mail address released in response to a public records request, do not send electronic mail to this entity. Instead, contact this office by phone or in writing.)
Please contact the Board of Pharmacy at (850) 245-4292 or by email at MQA_Pharmacy@doh.state.fl.us should you have any questions or concerns regarding this matter.
Prescription Drug Diversion Summit- On February 29, 2008 the Boards of Medicine, Osteopathic Medicine, Pharmacy and Nursing held a joint meeting to discuss pain management and prescription drug diversion issues in an effort to reduce the drug diversion problem in Florida, while assuring that patient access to appropriate and effective treatment of chronic pain is not compromised.
Below are links to the meeting summary and several presentations that were provided at the meeting:
Meeting Summary (66kb - pdf)
"Historical Overview” presented by Larry McPherson, Executive Director, Board of Medicine (311kb - pdf)
"Addressing Abuse and Diversion: An Overview of State Controlled Substances Data Bases” presented by the FSMB’s Lisa Robin (6mb - zip)
"Professional Impairment: The Lived Experience of Chemically Dependent Nurses” presented by Patricia Welch Dittman, PhD, RN, CHD (185kb - pdf)
"Integrative Pain Management, A Holistic Approach to Managing Chronic Pain” presented by Adrian Langford with Alternative Medicine Integration of Florida, Inc. (272kb - pdf)
Osteopathic Consumer Information Brochure (pdf - 1mb)
Need an Application Fast? Applications may be printed using Adobe Reader. |
